CheckMyRecalls

Chiesi USA, Inc. recalls CUROSURF (poractant alfa)

Published
1 Apr 2026
Units affected
7,235 vials
Agency
FDA
Country
United States

The hazard

Lack of Assurance of Sterility

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03.

Brand / company
Chiesi USA, Inc.
Codes / lots
Lot #: 1213748, Exp. Date 09/2026; 1215076, 1215077, Exp. Date 10/26.
Distribution
Nationwide within the United States
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 1 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.